Efficacy and Safety of Pembrolizumab Monotherapy or Combined Therapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Post time 6 day(s) ago

journal：Current Gene Therapy

Authors：Mahmood Araghi; Farshad Gharebakhshi; Fatemeh Faramarzi; Alireza Mafi; Tahoora Mousavi; Mina Alimohammadi; Hussein Soleimantabar

Published date：2025-2-

DOI：10.2174/0115665232283880240301035621

PDF link：https://www.eurekaselect.com/art ... 2283880240301035621

Article link：https://doi.org/10.2174/0115665232283880240301035621

Article Source：Bentham Science Publishers Ltd.。

Remark：

Post time 6 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Bentham] Efficacy and Safety of Pembrolizumab Monotherapy or Combined Therapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Bentham] Efficacy and Safety of Pembrolizumab Monotherapy or Combined Therapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Bentham] Efficacy and Safety of Pembrolizumab Monotherapy or Combined Therapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials